SPP Documents issued to Shareholders
SPP Documents issued to Shareholders
Brisbane, June 27, 2017 AEST (ABN Newswire) - Oventus Medical Limited (ASX:OVN) (Oventus) announced a share purchase plan (SPP) to the market on 22 June 2017. The record date to be registered as a shareholder for participation in the SPP is Wednesday, 21 June 2017.

Oventus is now in the process of mailing the SPP documents to its shareholders and, as required by the ASX Listing Rules, is releasing these documents to the market.

The following documents are being mailed to shareholders:

(a) offer letter and investment overview, which includes details on the pricing, timetable, intended use of funds and key risks of an investment in Oventus;

(b) SPP terms; and

(c) an application form.

If you have any questions about the SPP, please contact the offer information line on 1300-552-270 (within Australia) or +61-3-9415-4000 (outside Australia) between 9:00 a.m. and 5:00 p.m. (Brisbane time), Monday to Friday.

To view copies of these documents, please visit:

About Oventus Medical Ltd

Oventus Medical Ltd (ASX:OVN) is a Brisbane, Australia, based medical device company that has commercialized and brought to market a new sleep treatment platform for the treatment of sleep apnoea and snoring that enhances the treatment outcomes of both oral appliance therapy and CPAP therapy through increased efficacy and greater adherence.



Dr Mel Bridges
M: +61-41-3051-600

Kyahn Williamson
WE Buchan
P: +61-3-8866-1214
E: kwilliamson@buchanwe.com.au

Related Companies

Oventus Medical Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 23) (Last 30 Days: 109) (Since Published: 2446) 

Oventus Medical Ltd NEWS: RECENT VISITS (4695)